Skip to main content

Glimepiride

NDC 51655-565 · Northwind Health Company, LLC

Generic nameGlimepiride
Dosage formTABLET
RouteORAL
Active ingredient(s)GLIMEPIRIDE
Strength2 mg/1
Pharmacologic classSulfonylurea Compounds [CS], Sulfonylurea [EPC]
Marketing categoryANDA

Packages

51655-565-26 — 90 TABLET in 1 BOTTLE, PLASTIC (51655-565-26)

51655-565-52 — 30 TABLET in 1 BOTTLE, PLASTIC (51655-565-52)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-7406 — Glimepiride, 50090-7407 — Glimepiride, 50090-7628 — Glimepiride, 50090-7823 — Glimepiride, 50268-358 — Glimepiride, 50268-359 — Glimepiride, 50268-360 — Glimepiride, 51655-120 — Glimepiride, 51655-383 — Glimepiride, 51655-489 — Glimepiride, 55111-320 — Glimepiride, 55111-321 — Glimepiride, 55111-322 — Glimepiride, 55154-8175 — Glimepiride, 60429-918 — Glimepiride, 60429-919 — Glimepiride, 60429-920 — Glimepiride, 60760-800 — Glimepiride, 60760-845 — Glimepiride, 61442-115 — Glimepiride, +86 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels